CID 131751333

4,5-dihydroniveusin a

Structural Information

Molecular Formula
C20H28O8
SMILES
C/C=C(/C)\C(=O)OC1CC2(C(CC(O2)(C(CC3C1C(=C)C(=O)O3)CO)O)O)C
InChI
InChI=1S/C20H28O8/c1-5-10(2)17(23)27-14-7-19(4)15(22)8-20(25,28-19)12(9-21)6-13-16(14)11(3)18(24)26-13/h5,12-16,21-22,25H,3,6-9H2,1-2,4H3/b10-5-
InChIKey
SNUZCOSRHAIVKC-YHYXMXQVSA-N
Compound name
[1,12-dihydroxy-2-(hydroxymethyl)-11-methyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.04,8]tetradecan-9-yl] (Z)-2-methylbut-2-enoate
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

396.1784 Da
Monoisotopic Mass

1.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 397.185676 218.6
[M+Na]+ 419.167618 218.6
[M-H]- 395.171124 217.7
[M+NH4]+ 414.212223 217.8
[M+K]+ 435.141558 216.7
[M+H-H2O]+ 379.175660 209.3
[M+HCOO]- 441.176601 218.0
[M+CH3COO]- 455.192251 218.0
[M+Na-2H]- 417.153066 217.8
[M]+ 396.17785142 217.7
[M]- 396.17894858 217.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.